Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 4 Jun 2002, 0:00 Forim - Audited Results For The Year Ended 28
Forim - Audited Results for the Year Ended 28 February 2002                     
FORIM HOLDINGS LIMITED                                                          
   (Incorporated in the Republic of South Africa)                               
(Registration number 1986/004111/06)                                         
   JSE Share code: FOM   ISIN ZAE000002689                                      
   ("Forim" or "the group")                                                     
AUDITED RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2002                             
CONSOLIDATED INCOME STATEMENT                                                   
                                        Year ended      Year ended              
                                        28/02/2002      28/02/2001              
                                        audited         audited                 
R`000           R`000                   
Turnover                                193 262         160 593                 
Cost of sales                           140 921         114 455                 
Gross profit                            52 341          46 138                  
Operating costs                         48 060          42 064                  
Operating profit before amortisation    4 281           4 074                   
Amortisation of goodwill,                                                       
  patents and trade marks               1 500           1 500                   
Operating profit                        2 781           2 574                   
Net finance costs                       (2 267)         (2 447)                 
Profit before taxation                  514             127                     
Taxation                                719             773                     
Loss after taxation                     (205)           (646)                   
Loss attributable to                                                            
  minority shareholders                 (139)           (309)                   
Loss on change of interest                                                      
in subsidiary                                         (894)                   
Net loss attributable to members        (344)           (1 849)                 
Shares in issue (000`s)                 50 000          50 000                  
Earnings per share (cents)              (1,9)           (3,7)                   
Headline earnings per share (cents)     1,6             (0,7)                   
Reconciliation of headline earnings                                             
  to earnings                                                                   
Earnings                                (344)           (1 849)                 
Add: amortisation of goodwill,                                                  
     patents and trademarks             1 500           1 500                   
     loss on change of interest                                                 
     in subsidiary                                      894                     
Less: taxation                          (174)           (174)                   
                                        982             371                     
Minority interest                       (164)           (164)                   
Headline earnings                       818             207                     
CONSOLIDATED BALANCE SHEET                                                      
                                        28/02/2002      28/02/2001              
                                        audited         audited                 
                                        R`000           R`000                   
Assets                                                                          
Tangible fixed assets                   33 488          31 839                  
Pharmaceutical registrations,                                                   
goodwill, patents and trademarks        29 947          31 388                  
Other financial assets                  379             379                     
Deferred taxation                       305             176                     
Current assets                          77 101          70 296                  
Inventories                             37 119          33 059                  
Accounts receivable                     32 551          30 038                  
Taxation                                1 326           840                     
Cash and cash equivalents               6 105           6 359                   
Total assets                            141 220         134 078                 
Equities and liabilities                                                        
Shareholders` interest                  54 258          55 235                  
Outside shareholders` interest          31 944          31 805                  
Non-current liabilities                 2 986           4 483                   
Deferred taxation                       1 400           1 098                   
Current liabilities                     50 632          41 457                  
Interest bearing borrowings             2 722           1 540                   
Taxation                                476             340                     
Accounts payable                        35 467          28 307                  
Bank overdraft                          11 967          11 270                  
Total equities and liabilities          141 220         134 078                 
Net asset value per share (cents)       108,5           110,5                   
CONSOLIDATED CASH FLOW STATEMENT                                                
                                        Year ended      Year ended              
                                        28/02/2002      28/02/2001              
                                        audited         audited                 
R`000           R`000                   
Cash generated from operations          7 450           5 110                   
Net interest paid                       (2 266)         (2 447)                 
Taxation paid                           (897)           (2 438)                 
Secondary tax paid                      -               (310)                   
Dividends paid                          -               (764)                   
Net cash flow from operating activities 4 287           (849)                   
Net cash flow from investing activities (4 922)         (767)                   
Net cash flow from financing activities (315)           (2 400)                 
Net decrease in cash and                                                        
  cash equivalents                      (950)           (4 016)                 
Cash and cash equivalents/                                                      
(overdrafts) at beginning of year       (4 911)         (895)                   
Cash and cash equivalents/                                                      
(overdrafts) at end of year             (5 861)         (4 911)                 
STATEMENT OF CHANGES IN EQUITY                                                  
Non-                                
                                            distribu- Distribu-                 
                        Share     Share     table     table                     
                        capital   premium   reserve   reserve   Total           
R`000     R`000     R`000     R`000     R`000           
Balance at                                                                      
1 March 2000            500       23 257    495       32 832    57 084          
Net loss for period                                   (1 849)   (1 849)         
Transfer from non-                                                              
distributable reserve                       (45)      45        -               
Balance at                                                                      
28 February 2001        500       23 257    450       31 028    55 235          
Change in accounting                                                            
policy of land and                                                              
buildings to fair value                               (633)     (633)           
Restated balance at                                                             
1 March 2001            500       23 257    450       30 395    54 602          
Net loss for year                                     (344)     (344)           
Transfer from                                                                   
non-distributable reserve                   (45)      45        -               
Balance at                                                                      
28 February 2002         500      23 257    405       30 096    54 258          
NOTES                                                                           
1. Results                                                                      
The major activities of the group are conducted by its listed subsidiary,    
Alliance Pharmaceuticals Limited ("Alliance"), in pharmaceuticals, medical      
and surgical disposables, manufacture and distribution of generic medicines,    
the admixture of parenteral nutrition and the marketing and distribution of     
consumer personalcare products.  Shareholders are referred to the               
announcement of Alliance`s audited results for the year ended 28 February       
2002, published simultaneously with this announcement.                          
   In addition, the group continues to own properties situated in and around    
the Johannesburg Central Business District.                                     
   Turnover increased by 20,3% over that of the same period last year.  Loss    
per share amounted to 1,9 cents for the current period compared to a loss of    
3,7 cents for the previous year and headline earnings per share increased to    
1,6 cents from a loss 0,7 cents over the previous year.                         
2. Accounting policies                                                          
   The audited financial statements have been prepared on the historical        
cost basis and in accordance with South African Statements of Generally         
Accepted Accounting Practice. The accounting policies applied are consistent    
with those applied in the annual financial statements of the previous           
financial year, with the exception of the carrying value of land and            
buildings. The group has changed its accounting policy relating to the          
carrying value of land and buildings and now accounts for land and buildings    
at fair value. Land and buildings were valued at 28 February 2002 and the       
loss arising from the change to fair value is reflected as a change to          
opening retained income as it was accepted that no major change in value had    
occured between 1 March 2001 and 28 February 2002.                              
3. Directorate                                                                  
   Mr Yaseen Bhayat was appointed to the board of directors on 18 April         
2002. Dr Harold Serebro resigned from the board on 8 May 2002.                  
4. Dividends                                                                    
   In order to preserve the group`s cash resources, no dividend has been        
declared.                                                                       
   For and on behalf of the board                                               
H R Levin          M Gelbart                                                 
   Chairman           Managing Director                                         
   31 May 2002                                                                  
Directors:                                                                      
H R Levin* (Chairman), M Gelbart (Managing), Y Bhayat*,                      
   J E Forman (*non-executive)                                                  
Transfer Secretaries:                                                           
   Computershare Investor Services Limited,                                     
11 Diagonal Street, Johannesburg, 2001                                       
   (PO Box 1053, Johannesburg, 2000)                                            
Company Secretary:                                                              
   Executive Secretarial Services CC,                                           
PO Box 261269, Excom, 2023
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: